Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
stockwatch.in » Stock Watch - Stock Specific News - Nov 8, 2008
Finally, Japan based drug maker Daiichi Sankyo has completed the acquisition process of Indian drug maker Ranbaxy Laboratories on Friday. The Japanese drug maker acquired remaining 11.4% stake for Rs 3,537.6 crore and …
Also tagged: pharmaceutical sector, daiichi sankyo, company updates
stockwatch.in » Stock Watch - Stock Specific News - Oct 24, 2008
Ranbaxy Labs good for long term investment. The company has a robust growth model and the recent fall in valuations makes the stock even more attractive. There are some issues which are a big concern for the company …
Also tagged: pharmaceutical sector, buzzing stocks
businesspundit.com » Business Pundit - Oct 6, 2008
Someone needs to make a movie about Carl Icahn. The all-star corporate raider is at it again. Icahn, who chairs the notorious pharmaceutical company ImClone’s board, has accepted a $70/share buyout of the company. From …
Also tagged: investing, companies, novartis, eli lilly, carl icahn, eli lily, imclone, cookson, business pundit news, imclone sale
stockwatch.in » Stock Watch - Stock Specific News - Sep 18, 2008
<!--[if gte mso 9]> read more
Also tagged: india business, pharmaceutical sector, company updates
consumerist.com » Consumerist - Sep 17, 2008
The FDA has banned the import of 30 different generic drugs made by Ranbaxy due to unresolved ongoing concerns about quality controls in the manufacturing process. Some of them are popular, like a generic for Zocor …
Also tagged: health, generics, fda, readers, zocor, pharma, consumer alert
stockwatch.in » Stock Watch - Stock Specific News - Aug 1, 2008
Pharmaceutical major Ranbaxy has informed that the World Health Organisation (WHO) has approved its anti-retro viral drug Abacavir 300 mg tablets in pre-qualification list. Abacavir will be manufactured at Ranbaxy's …
Also tagged: pharmaceutical sector
fiercehealthcare.com » News - Jul 17, 2008
> The ongoing series of probes into the business practices of generic drug manufacturer Ranbaxy is steadily widening. FiercePharma > Researchers have found a vaccine that, at mid-stage trials, seems to be …
Also tagged: commercial real estate, brain cancer, reits, drug manufacturer, real estate investment trusts, evanston northwestern healthcare
fiercehealthcare.com » News - Jul 15, 2008
> Pharmaceutical companies have been cutting sales forces recently. The most recent is Boehringer Ingelheim, which will halve the ranks of its neurology sales force. FiercePharma > The ongoing investigation of …
Also tagged: hiv, boehringer ingelheim, prevnar, pneumococcus vaccine, generic drug maker, hiv drugs
bloggingstocks.com » BloggingStocks - Jun 14, 2008
Filed under: Pfizer (PFE), Merck and Co (MRK) There is a report out of Reuters that may get the drug sector up in a whirlwind if it comes to pass. The implications aren't just that Pfizer Inc. may want to try to …
Also tagged: mrk, pfe, biotech, pfizer, merck, generic drugs, genericdrugs, daiichi sankyo, indian generics, indiangenerics
bloggingstocks.com » BloggingStocks - Jun 13, 2008
Filed under: Pfizer (PFE), Merck and Co (MRK) There is a report out of Reuters that may get the drug sector up in a whirlwind if it comes to pass. The implications aren't just that Pfizer Inc. may want to try to …
Also tagged: biotech, pfizer, merck, generic drugs, genericdrugs, daiichi sankyo, indian generics, indiangenerics